Deucravacitinib

deucravacitinib · Bristol Myers Squibb

Drug timelines are a Plus or Pro feature.

30 regulatory and trial events tracked for Deucravacitinib, covering 2022-07-06 to 2026-08-26. Get the full timeline:

Most recent: Clinical Trial Results: Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris [Phase 2]